151 related articles for article (PubMed ID: 37774790)
1. Analysis of Magnetic Resonance Imaging Perfusion Parameters for the Identification of Spinal Metastatic Tumors with Rich Blood Supply.
Guo GH; He QJ; Zhang XL; Jiao YQ; Wang M; Li FX
World Neurosurg; 2023 Dec; 180():e506-e513. PubMed ID: 37774790
[TBL] [Abstract][Full Text] [Related]
2. Dynamic contrast-enhanced magnetic resonance perfusion compared with digital subtraction angiography for the evaluation of extradural spinal metastases: a pilot study.
Mazura JC; Karimi S; Pauliah M; Banihashemi MA; Gobin YP; Bilsky MH; Patsalides A
Spine (Phila Pa 1976); 2014 Jul; 39(16):E950-4. PubMed ID: 24827525
[TBL] [Abstract][Full Text] [Related]
3. Intra-Arterial MR Perfusion Imaging of Meningiomas: Comparison to Digital Subtraction Angiography and Intravenous MR Perfusion Imaging.
Lum MA; Martin AJ; Alexander MD; McCoy DB; Cooke DL; Lillaney P; Moftakhar P; Amans MR; Settecase F; Nicholson A; Dowd CF; Halbach VV; Higashida RT; McDermott MW; Saloner D; Hetts SW
PLoS One; 2016; 11(11):e0163554. PubMed ID: 27802268
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance perfusion characteristics of hypervascular renal and hypovascular prostate spinal metastases: clinical utilities and implications.
Saha A; Peck KK; Lis E; Holodny AI; Yamada Y; Karimi S
Spine (Phila Pa 1976); 2014 Nov; 39(24):E1433-40. PubMed ID: 25188594
[TBL] [Abstract][Full Text] [Related]
5. Role of dynamic perfusion magnetic resonance imaging in patients with local advanced rectal cancer.
Ippolito D; Drago SG; Pecorelli A; Maino C; Querques G; Mariani I; Franzesi CT; Sironi S
World J Gastroenterol; 2020 May; 26(20):2657-2668. PubMed ID: 32523318
[TBL] [Abstract][Full Text] [Related]
6. T1-weighted Dynamic Contrast-enhanced MRI to Differentiate Nonneoplastic and Malignant Vertebral Body Lesions in the Spine.
Guan Y; Peck KK; Lyo J; Tisnado J; Lis E; Arevalo-Perez J; Yamada Y; Hameed MR; Karimi S; Holodny A
Radiology; 2020 Nov; 297(2):382-389. PubMed ID: 32870135
[TBL] [Abstract][Full Text] [Related]
7. Dynamic Contrast-Enhanced Sonography and Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Preoperative Diagnosis of Infected Nonunions.
Fischer C; Preuss EM; Tanner M; Bruckner T; Krix M; Amarteifio E; Miska M; Moghaddam-Alvandi A; Schmidmaier G; Weber MA
J Ultrasound Med; 2016 May; 35(5):933-42. PubMed ID: 27036169
[TBL] [Abstract][Full Text] [Related]
8. Dynamic contrast-enhanced MRI for the assessment of spinal tumor vascularity: correlation with angiography.
Meng XX; Zhang YQ; Liao HQ; Liu HC; Jiang HL; Ke SJ; Dong WH
Eur Spine J; 2016 Dec; 25(12):3952-3961. PubMed ID: 27448809
[TBL] [Abstract][Full Text] [Related]
9. Differentiating Atypical Hemangiomas and Metastatic Vertebral Lesions: The Role of T1-Weighted Dynamic Contrast-Enhanced MRI.
Morales KA; Arevalo-Perez J; Peck KK; Holodny AI; Lis E; Karimi S
AJNR Am J Neuroradiol; 2018 May; 39(5):968-973. PubMed ID: 29650780
[TBL] [Abstract][Full Text] [Related]
10. Measurement of blood perfusion in spinal metastases with dynamic contrast-enhanced magnetic resonance imaging: evaluation of tumor response to radiation therapy.
Chu S; Karimi S; Peck KK; Yamada Y; Lis E; Lyo J; Bilsky M; Holodny AI
Spine (Phila Pa 1976); 2013 Oct; 38(22):E1418-24. PubMed ID: 23873238
[TBL] [Abstract][Full Text] [Related]
11. Reliability and accuracy of time-resolved contrast-enhanced magnetic resonance angiography in hypervascular spinal metastases prior embolization.
Premat K; Shotar E; Burns R; Shor N; Eloy G; Cormier É; Drir M; Morardet L; Lenck S; Sourour N; Chiras J; Dormont D; Bonaccorsi R; Clarençon F
Eur Radiol; 2021 Jul; 31(7):4690-4699. PubMed ID: 33449182
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
[TBL] [Abstract][Full Text] [Related]
13. Dynamic Contrast-Enhanced Magnetic Resonance Imaging With Gadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid for Quantitative Assessment of Vascular Effects on Hepatocellular-Carcinoma Lesions Treated by Transarterial Chemoembolization or Radiofrequency Ablation.
Ippolito D; Trattenero C; Talei Franzesi C; Casiraghi A; Lombardi S; Vacirca F; Corso R; Sironi S
J Comput Assist Tomogr; 2016; 40(5):692-700. PubMed ID: 27560010
[TBL] [Abstract][Full Text] [Related]
14. Impact of non-contrast enhanced volumetric MRI-based feeder localization in the treatment of spinal dural arteriovenous fistula.
Kannath SK; Thomas B; Sankara Sarma P; Enakshy Rajan J
J Neurointerv Surg; 2017 Feb; 9(2):178-182. PubMed ID: 27557942
[TBL] [Abstract][Full Text] [Related]
15. Rat model of reperfused partial liver infarction: characterization with multiparametric magnetic resonance imaging, microangiography, and histomorphology.
Wu X; Wang H; Chen F; Jin L; Li J; Feng Y; DeKeyzer F; Yu J; Marchal G; Ni Y
Acta Radiol; 2009 Apr; 50(3):276-87. PubMed ID: 19160078
[TBL] [Abstract][Full Text] [Related]
16. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
[TBL] [Abstract][Full Text] [Related]
17. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.
Uhl M; Saueressig U; van Buiren M; Kontny U; Niemeyer C; Köhler G; Ilyasov K; Langer M
Invest Radiol; 2006 Aug; 41(8):618-23. PubMed ID: 16829744
[TBL] [Abstract][Full Text] [Related]
18. Distinguishing mesorectal tumor deposits from metastatic lymph nodes by using diffusion-weighted and dynamic contrast-enhanced magnetic resonance imaging in rectal cancer.
Xu Q; Xu Y; Wang J; Sun H; Lin J; Xie S
Eur Radiol; 2023 Jun; 33(6):4127-4137. PubMed ID: 36520180
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of grade II and III oligodendrogliomas from grade II and III astrocytomas: a histogram analysis of perfusion parameters derived from dynamic contrast-enhanced (DCE) and dynamic susceptibility contrast (DSC) MRI.
Lee JY; Ahn KJ; Lee YS; Jang JH; Jung SL; Kim BS
Acta Radiol; 2018 Jun; 59(6):723-731. PubMed ID: 28862024
[TBL] [Abstract][Full Text] [Related]
20. Dynamic contrast-enhanced magnetic resonance imaging measurements in renal cell carcinoma: effect of region of interest size and positioning on interobserver and intraobserver variability.
Braunagel M; Radler E; Ingrisch M; Staehler M; Schmid-Tannwald C; Rist C; Nikolaou K; Reiser MF; Notohamiprodjo M
Invest Radiol; 2015 Jan; 50(1):57-66. PubMed ID: 25260094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
